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1434 Abstracts November 2013organs. Another 38.2% (100) had struts immediately adjacent to the
external aspect of the IVC, which may represent tenting of the cava. Grade
2 or 3 penetration occurred in 74.4% of Celects, 44.6% of Tulips, 5.3% of
Greenﬁelds, and 0% of Opteases (P ¼ .0000). Grade 2 or 3 penetration
occurred in 49.0% of temporary ﬁlters but only 5.3% of permanent ﬁlters
(P ¼ .0001). There was a trend toward association of uniconical ﬁlters
with grade 2 or 3 penetration (P ¼ .0645). Grade 2 or 3 penetration
occurred in 18.2% of ﬁlters less than 30 days old but in 57.3% of ﬁlters
30 days old or older (P < .0001). Thirty-two patients had subsequent
encounters for abdominal or back pain, but none were conclusively related
to penetration.
Conclusions: A majority of ﬁlters were placed for prophylaxis
or relative indications and were temporary type. Retrieval rate is
low. Penetration of the IVC and adjacent organs is common and asso-
ciated with temporary type and length of time in place. It is unclear if
most penetrations cause problems. Monitoring of penetrations with
CT may be important to understand the natural history of this
condition.
Table.
CT ﬁndings GradeStruts conﬁned entirely within IVC 0
Strut immediately adjacent to external aspect of
IVC wall (“tenting”)
1Strut entirely outside IVC lumen (“halo” of
retroperitoneal fat around strut)2Strut interacts with aorta 3a
Strut interacts with duodenum 3b
Strut interacts with other organs 3cCT, Computed tomography; IVC, inferior vena cava.Thoracic Aortic Diameter Changes After Endograft Placement:
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Objectives: This study evaluates acute changes in aortic size before
and after endograft placement for traumatic injury and aneurysmal disease.
We hypothesized that characteristics speciﬁc to trauma patients undergoing
thoracic endovascular aortic repair (TEVAR), such as hypovolemia or local-
ized spasm around the aortic injury, may result in relative device
undersizing.
Methods: This was a retrospective study that evaluated digital
imaging of traumatic injury and aneurysmal patients enrolled in the 0802
and 0803 multi-site trials that received the GORE Conformable TAG
thoracic device (W. L Gore and Associates, Flagstaff, Ariz). Pre- and post-
treatment (30-day) imaging was available for 70 traumatic injury and 54
aneurysmal patients. A standardized protocol was used by an independent
single observer to complete measurements of the proximal and distal
maximum neck diameters adjacent to the pathology using the orthogonal
view on pre- and posttreatment imaging. The resultant changes in diameter
for each group were analyzed using t-tests. The study was limited by lack of
intraprocedural imaging and clinical information on the selection of device
sizing.
Results: There was signiﬁcant difference between patients with trau-
matic and aneurysmal disease in the changes of the proximal and distal
neck diameters from the pre- and posttreatment imaging. In traumatic
injury patients, the proximal and distal maximum aortic neck diameters
were found to increase after TEVAR signiﬁcantly more than in patients
with aneurysmal disease. The range that the neck diameters changed was
greater for patients with traumatic injuries than with aneurysmal disease.
In both study populations, smaller pretreatment aortic neck diameters
showed a larger change in neck diameter than larger pretreatment aortic
diameters. Aortic growth correlated with pretreatment neck diameter and
oversizing.
Conclusions: The proximal and distal maximum aortic neck diame-
ters in traumatic injury patients increased signiﬁcantly more from the pre-and posttreatment imaging than in patients with aneurysmal disease.
Pretreatment neck diameter and percent oversizing correlate with the
change in the neck diameter. Despite these aortic changes, TEVAR with
this device is effective over a wide sizing range.
Table.
Change in distalSummary
of analysisChange in proximal
neck diameter (mm)
(mean, range, variance)neck diameter (mm)
(mean, range,
variance)Traumatic injury 3.06 (3.59 to 9.47) 6.86 2.99 (1.61 to 13.69) 4.78
Aneurysmal
disease
2.06 (2.89 to 5.72) 3.46 0.67 (5.67 to 4.34) 3.08P value
(trauma vs
aneurysm).019 <.001Post-Approval Outcomes of Juxtarenal Aortic Aneurysms Treated with
the Zenith Fenestrated Endovascular Graft
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Objectives: To evaluate postapproval outcomes of patients with jux-
tarenal aortic aneurysms (JRAAs) treated with Zenith Fenestrated Endovas-
cular Graft (zFEN).
Methods: We reviewed clinical data on consecutive patients treated
with zFEN in the US at seven institutions with early commercial access
from 7/12 to 12/12. Clinical outcomes and compliance to anatomical
guidelines were compared with results of the US fenestrated trial (USFT).
Results: Fifty-seven patients were treated. There were signiﬁcantly
more (P < .05) patients with coronary artery disease, myocardial infarction,
and preoperative renal insufﬁciency than in the USFT. Twenty-seven
patients (47%) did not meet the USFT anatomic criteria of a >4 mm infrare-
nal neck, and there were signiﬁcantly more mesenteric stents (13 vs 0; P <
.05) used in this group than in the USFT, reﬂecting the higher anatomical
complexity of these patients. The total operative time was 250.2 6 14.8
minutes, ﬂuoroscopy time was 68.9 6 4.47 minutes, and the average
contrast volume was 108.6 6 5.6 mL. Technical success was 100% in
regards to aneurysm exclusion, although in two patients the left renal fenes-
tration was not able to be aligned, and one patient had a kinked renal stent
that was successfully re-stented. During this time period, there were a total
of 10 endoleaks of which two were type 3 and eight were type II (Table).
Conclusions: Despite higher rates of comorbidities and more chal-
lenging anatomy, early 30-day outcomes of JRAAs treated postapproval
with zFEN compare well with USFT data.
Table.
Patient demographics Study zFEN trial
and 30-day outcomes patients patients P valueNo. 57 42
Age, years 73.3 75.3 .76
Coronary artery disease, n (%) 45 (79) 22 (52.4) <.05
Chronic obstructive pulmonary disease,
n (%)
21 (36.8) 14 (33.3) .83History of myocardial infarction, n (%) 34 (59.6) 10 (23.8) <.05
Technical success, n (%) 57 (100) 42 (100) 1.00
Mortality, n (%) 1 (1.75) 0 (0) 1.00
Postoperative dialysis, n (%) 1 (1.75) 0 (0) 1.00
Endoleak, n 10 9 .62Patient and Clinical Characteristics Associated with Readmission
Among Patients Undergoing Vascular Surgery
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Volume 58, Number 5 Abstracts 1435Objectives: Readmission following vascular surgery intervention is
frequent, costly, and often considered preventable. Vascular surgery
outcomes have recently been scrutinized by Medicare, given high rates of
readmission. We determine patient and clinical characteristics that predict
readmission in a cohort of vascular surgery patients.
Methods: From 2009 to 2013, the medical records of all patients
(n ¼ 2505) undergoing interventions by the vascular surgery service at
a single tertiary care institution were retrospectively reviewed. Sociodemo-
graphic and clinical characteristics were examined for association with 30-
day readmission.
Results: The 30-day readmission rate to the same institution was
9.7% (n ¼ 244). Procedures most likely to result in readmission were
below-knee (25%), foot (22%), and toe amputations (19%), as well as
lower extremity revisions (22%). Patients covered by Medicaid
(16.8%) and Medicare (10.0%) were most likely to be readmitted fol-
lowed by fee-for-service (9.5%), self-pay (8.0%), and health maintenance
organization (5.5%; P < .05). Patients urgently admitted were more
likely to be readmitted (16.2%) than electively admitted patients
(9.1%; P < .01). Patient severity (rated using 3M APR DRG software)
predicted readmission (16.2% high vs 6.2% low severity; P < .01). Initial
length of stay was longer for readmitted than nonreadmitted patients
(8.5 vs 6.1 days, respectively; P < .01). Intensive care unit admission
during initial hospitalization was moderately associated with higher
readmission rates (18.3% with vs 9.5% without intensive care unit
stay; P < .05). Discharge destination was also a strong predictor of
readmission (rehabilitation, 19.2%; skilled nursing facility, 16.2% vs
home, 6.2%; P < .01). The effects of urgent admission, illness severity,
length of stay, and discharge destination persisted in multivariable
logistic regression.
Conclusions: To reduce readmission rates effectively, institutions
must identify high-risk patients. Efforts should focus on subgroups under-
going selected interventions (amputations, vascular revisions), as well as
urgent admissions and those with extended hospital stays. Patients in
need of postacute care upon discharge are especially prone to readmission,
requiring special attention to discharge planning and coordination of post-
discharge care.
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Objectives: To compare the morbidities, mortality, length of stay,
and total cost between simultaneous and staged carotid endarterectomy
(CEA) and coronary artery bypass grafting (CABG).
Methods: Utilizing the Nationwide Inpatient Sample (NIS), we
studied all the patients that underwent CEA and CABG between 2008
and 2010. International Classiﬁcation of Disease, Ninth Revision codes
were used to look for procedure types, comorbidities, and complications.
Data analysis was done using SPSS v.19 (IBM, Armonk, NY); statistical
signiﬁcance was deﬁned as P < .05.
Results: Both CEA and CABG (CEA/CABG) was done in 8568
patients. CEA/CABG group was categorized into Simultaneous CEA/
CABG (SmCC; same day; 4534 [52.9%]), and Staged CEA/CABG
(StCC; different days, same admission; 2209 [25.8%]); 1825 (21.3%)Table. Adjusted and nonadjusted comparison of simultaneous and staged carot
Nonadjusted
Simultaneous Staged P
No. 4534 2209
LOS, days (median) 9 13 <.01
Total cost, USD (median) 124,544 171,094 <.01
Mortality 181/4% 98/4% .390
Myocardial infarction 1099/24% 558/25% .366
Stroke 90/2% 49/2% .528
LOS, Length of stay.
aStandardized coefﬁcient.patients were excluded (deﬁcient coding). When SmCC was compared
with StCC, Length of stay (LOS) and total charges were signiﬁcantly
higher in StCC; however, no signiﬁcant difference was found in
mortality, in-hospital myocardial infarction, or postoperative stroke.
After adjustment for comorbidities (hypertension, diabetes mellitus,
congestive heart failure, smoking and peripheral vascular disease),
comparison of SmCC and StCC yielded comparable results for LOS
and total charges, but no signiﬁcant differences in mortality, in-hospital
myocardial infarction, and postoperative stroke between SmCC and
StCC (Table).
Conclusions: In patients with combined CEA/CABG, simultaneous
surgery carries lower charges, LOS, mortality and stroke rate as compared
with staged procedures in the same admission.
Effect of Plavix on Limb Salvage Following Endovascular Lower
Extremity Revascularization
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Objectives: This study evaluated amputation-free-survival in patients
identiﬁed utilizing Plavix (Clopidogrel) following their lower extremity
endovascular revascularization (LER).
Methods: Patients 65 years of age and greater undergoing LER were
identiﬁed from MedPAR ﬁles (2007 to 2008) utilizing International Classi-
ﬁcation of Disease, Ninth Revision codes. Demographics, comorbidities,
and severity of disease (claudication, rest pain, ulceration/gangrene
[UG]) are evaluated. Postprocedural use of Plavix was identiﬁed using the
National Drug Code directory and Part D ﬁles. Outcomes were measured
using c2 analysis, multivariable logistic regression, Kaplan-Meier, and Cox
regression.
Results: A total of 14,353 patients were identiﬁed: 7189 with clau-
dication (50.1%), 1467 with rest pain (10.2%), 5697 with UG (39.7%).
Of these, 5416 (37.7%) patients were identiﬁed using Plavix after LER.
Overall, patients initiated on Plavix had lower amputation rates at 30
days (10.34% vs 14.09%; P < .0001), 90 days (14.05% vs 18.71%; P
< .0001), and 1 year (19.68% vs 24.06%; P < .0001). Multivariate
logistic regression analysis adjusted by age, gender, race, and comorbid-
ities conﬁrmed that non-Plavix users were more likely to undergo ampu-
tation at 30 days (odds ratio [OR], 1.28; 95% conﬁdence interval [CI],
1.14-1.43), 90 days (OR, 1.29; 95% CI, 1.16-1.43), and 1 year (OR,
1.16; 95% CI, 1.05-1.28). Males, blacks, congestive heart failure, dia-
betes, and renal failure were signiﬁcant predictors of amputation. In
c2, logistic regression, and Cox regression analyses, Plavix did not signif-
icantly affect amputation rates in patients with claudication or rest pain.
Patients with UG who did not receive Plavix were signiﬁcantly more
likely to undergo amputation at 30 days (OR, 1.29; 95% CI, 1.14-
1.45), 90 days (OR, 1.28; 95% CI, 1.15-1.43), and 365 days (OR,
1.19; 95% CI, 1.07-1.31).
Conclusions: Utilization of Plavix after LE endovascular revasculari-
zation was associated with lower rates of amputation, yet only 38% of the
Medicare population was identiﬁed as using Plavix after intervention.
Patients with UG beneﬁted the greatest with signiﬁcantly greater amputa-
tion-free survival and overall survival. Prospective randomized trials are
needed to assess the suggested beneﬁts of Plavix on amputation-free survival
after LE endovascular revascularization.id endarterectomy (CEA) and coronary artery bypass grafting (CABG)
Adjusted
Odds ratio P 95% conﬁdence interval
0.182a <.01 3.178 3.965
0.070a <.01 14641 24291
0.943 .671 0.720 1.236
0.994 .924 0.880 1.123
0.878 .478 0.613 1.258
